Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

67
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
67
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

78
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
78
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

157
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
157
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

55
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
55

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Drug Induced Thrombotic Microangiopathy in Cancer Patients: A Clinicopathologic Series.

Kidney360·2026
Same author

Utilizing Micro-RNA-371a-3p for Recurrence Prediction in Clinical Stage I Testicular Cancer.

The oncologist·2026
Same author

Persistent Pyelonephritis and Renal Abscess due to <i>Mycoplasma hominis</i> in an Immunocompromised Patient: A Case Report.

Case reports in infectious diseases·2026
Same author

Making the invisible visible: a case study of the healing hearts initiative within the SEED wellbeing program in Australian healthcare.

Frontiers in psychology·2026
Same author

Clinical and molecular correlates of circulating tumor fraction in patients with metastatic pancreatic ductal adenocarcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

ZNF274 constrains lineage plasticity and drives intrinsic resistance to CDK7 inhibitors in pancreatic cancer.

Nature communications·2026

関連する実験動画

Updated: Sep 10, 2025

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
13:25

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish

Published on: May 15, 2021

5.9K

シスプラチン治療後の慢性腎疾患の予測

Robert C Grant1,2,3, Jiang Chen He1,2, Ning Liu3

  • 1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

JAMA oncology
|August 21, 2025
PubMed
まとめ

シスプラチンの化学療法で 腎臓が損傷する可能性があります 基礎腎機能 (eGFR) を用いた単純なモデルは,治療後に慢性腎疾患 (CKD) のリスクを効果的に予測し,臨床決定に役立ちます.

さらに関連する動画

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
06:38

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on: March 11, 2016

12.2K
Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

1.9K

関連する実験動画

Last Updated: Sep 10, 2025

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
13:25

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish

Published on: May 15, 2021

5.9K
Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
06:38

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on: March 11, 2016

12.2K
Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

1.9K

科学分野:

  • 腎臓科
  • 腫瘍学
  • 臨床流行病学

背景:

  • シスプラチンは肝臓毒性のある重要な化学療法剤です.
  • シスプラチン投与後の慢性腎疾患 (CKD) のリスクと予測可能性は十分に理解されていません.
  • リスクのある患者の早期発見は介入に不可欠です.

研究 の 目的:

  • シスプラチン治療後のCKDの発生率を決定する.
  • シスプラチン投与後のCKDの予測モデルの有効性を評価する.
  • シスプラチン誘発性腎臓毒性の主要な予測要因を特定する.

主な方法:

  • 人口ベースの予後研究で,遡及的および前向きなコホートを使用します.
  • 人口統計,臨床データ,患者の報告した症状を用いた予測モデルの開発と検証
  • 腎臓機能の評価のための推定グルメルフィルタレーション率 (eGFR) の分析

主要な成果:

  • 前発性CKDのない患者の13. 6%がシスプラチン治療後にCKDを発症した.
  • 治療前のeGFRのみを用いた単純な脊髄回帰モデルは,CKDのリスクを正確に予測した.
  • 複雑な機械学習モデルは 基本のeGFRベースのモデルを上回らなかった.

結論:

  • シスプラチンの治療は,予想される腎機能の低下につながる.
  • シスプラチン投与後のCKDの発症の主なリスク因子である.
  • eGFRベースの予測モデルは,臨床管理を導き,患者のケアをパーソナライズすることができます.